On January 7, 2019, Dr. Bertolino, the Companyâ€
Post# of 72440
On January 7, 2019, Dr. Bertolino, the Company’s President and Chief Medical Officer, joined the Board of Directors. The Company is currently exploring options for further Board additions in preparation for late-stage clinical trials and ongoing portfolio development.
Sure do drag their feet.